Cargando…

Pathological Role of Angiotensin II in Severe COVID-19

The activated renin–angiotensin system induces a prothrombotic state resulting from the imbalance between coagulation and fibrinolysis. Angiotensin II is the central effector molecule of the activated renin–angiotensin system and is degraded by the angiotensin-converting enzyme 2 to angiotensin (1–7...

Descripción completa

Detalles Bibliográficos
Autor principal:	Miesbach, Wolfgang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Georg Thieme Verlag KG 2020
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7319800/ https://www.ncbi.nlm.nih.gov/pubmed/32607467 http://dx.doi.org/10.1055/s-0040-1713678

Ejemplares similares

COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation
por: Miesbach, Wolfgang, et al.
Publicado: (2020)

COVID-19 and the RAAS—a potential role for angiotensin II?
por: Busse, Laurence W., et al.
Publicado: (2020)

Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Blockers With Severity of COVID-19: A Multicenter, Prospective Study
por: Hakeam, Hakeam A., et al.
Publicado: (2020)

Role of angiotensin II in aging
por: Yi, Wenmin, et al.
Publicado: (2022)

Receptor Interactions of Angiotensin II and Angiotensin Receptor Blockers—Relevance to COVID-19
por: Moore, Graham J., et al.
Publicado: (2021)

The association of COVID-19 occurrence and severity with the use of angiotensin converting enzyme inhibitors or angiotensin-II receptor blockers in patients with hypertension
por: Li, Mingfei, et al.
Publicado: (2021)

The role of plasma angiotensin II and angiotensin-converting enzyme 2 levels on prognosis and mortality in hypertensive patients with COVID-19
por: Biberoğlu, Serap, et al.
Publicado: (2021)

Severe COVID-19 induces autoantibodies against angiotensin II that correlate with blood pressure dysregulation and disease severity
por: Briquez, Priscilla S., et al.
Publicado: (2022)

Use of Antihypertensive Drugs and Ischemic Stroke Severity – Is There a Role for Angiotensin-II?
por: Hwong, Wen Yea, et al.
Publicado: (2016)

Angiotensin II administration to COVID-19 patients is not advisable
por: Speth, Robert C.
Publicado: (2020)

Differential Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on COVID-19
por: Su, Lianjiu, et al.
Publicado: (2021)

Angiotensin II induces reactive oxygen species, DNA damage, and T-cell apoptosis in severe COVID-19
por: Kundura, Lucy, et al.
Publicado: (2022)

Angiotensin II - A Brief Review and Role in Severe SARS-COV-2 Sepsis
por: Carà, Gianmarco A., et al.
Publicado: (2022)

Treatment with angiotensin II in COVID-19 patients may not be beneficial
por: Rysz, Susanne, et al.
Publicado: (2020)

Intoxication With Endogenous Angiotensin II: A COVID-19 Hypothesis
por: Sfera, Adonis, et al.
Publicado: (2020)

Predictors of severe or lethal COVID-19, including Angiotensin Converting Enzyme inhibitors and Angiotensin II Receptor Blockers, in a sample of infected Italian citizens
por: Bravi, Francesca, et al.
Publicado: (2020)

The pivotal role of the angiotensin-II–NF-κB axis in the development of COVID-19 pathophysiology
por: Okamoto, Hiroshi, et al.
Publicado: (2020)

Angiotensin‐Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Outcomes in Patients Hospitalized for COVID‐19
por: Pan, Michael, et al.
Publicado: (2021)

Expression of ACE2, Soluble ACE2, Angiotensin I, Angiotensin II and Angiotensin-(1-7) Is Modulated in COVID-19 Patients
por: Osman, Ikram Omar, et al.
Publicado: (2021)

Angiotensin‐converting enzyme inhibitors and angiotensin II receptor blockers are not associated with severe COVID‐19 infection in a multi‐site UK acute hospital trust
por: Bean, Daniel M., et al.
Publicado: (2020)

Medikamentöse Thrombose-Prophylaxe bei ambulanten COVID-19-Patienten
por: Darius, Harald, et al.
Publicado: (2021)

Brain angiotensin II in dopaminergic imbalance-derived pathologies: neuroinflammation and vascular responses
por: Occhieppo, Victoria Belén, et al.
Publicado: (2020)

Loss of Apelin Augments Angiotensin II-Induced Cardiac Dysfunction and Pathological Remodeling
por: Sato, Teruki, et al.
Publicado: (2019)

Role of endothelial cells and angiotensin converting enzyme-II in COVID-19 and brain damages post-infection
por: Mehboob, Riffat, et al.
Publicado: (2023)

Angiotensin Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker Use Among Outpatients Diagnosed With COVID-19
por: Bae, David J., et al.
Publicado: (2020)

From Angiotensin II to Cyclic Peptides and Angiotensin Receptor Blockers (ARBs): Perspectives of ARBs in COVID-19 Therapy
por: Matsoukas, John, et al.
Publicado: (2021)

β-Arrestin–Biased Angiotensin II Receptor Agonists for COVID-19
por: Manglik, Aashish, et al.
Publicado: (2020)

Angiotensin II, III, and IV may be important in the progression of COVID-19
por: Cure, Erkan, et al.
Publicado: (2020)

COVID-19: angiotensin II in development of lung immunothrombosis and vasculitis mimics
por: Lloyd-Jones, Graham, et al.
Publicado: (2021)

Neurological effects of elevated levels of angiotensin II in COVID-19 patients
por: Khezri, Mohammad Rafi, et al.
Publicado: (2021)

Association of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers with risk of COVID‐19, inflammation level, severity, and death in patients with COVID‐19: A rapid systematic review and meta‐analysis
por: Liu, Xiao, et al.
Publicado: (2020)

Cardiomyocyte-Specific Deletion of Orai1 Reveals Its Protective Role in Angiotensin-II-Induced Pathological Cardiac Remodeling
por: Segin, Sebastian, et al.
Publicado: (2020)

Roles of Brain Angiotensin II in Cognitive Function and Dementia
por: Mogi, Masaki, et al.
Publicado: (2012)

Proinflammatory Role of Angiotensin II in the Aorta of Normotensive Mice
por: de Lima, Rariane Silva, et al.
Publicado: (2019)

Implications of haemophilia gene therapy for the changing role of the multidisciplinary team
por: Miesbach, Wolfgang, et al.
Publicado: (2021)

COVID-19 and relative angiotensin-converting enzyme 2 deficiency: role in disease severity and therapeutic response
por: Ryan, Paul MacDaragh, et al.
Publicado: (2020)

Two hits to the renin‐angiotensin system may play a key role in severe COVID‐19
por: Tseng, Yu‐Hsin, et al.
Publicado: (2020)

Impact of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Hypertensive Patients with COVID-19 (COVIDECA Study)
por: Mustafic, Hazrije, et al.
Publicado: (2021)

The role of angiotensin I converting enzyme insertion/deletion polymorphism in the severity and outcomes of COVID-19 patients
por: Rezaei, Mitra, et al.
Publicado: (2022)

440 Role of angiotensin II in SARS-CoV-2 pathophysiology in a hamster model of COVID-19
por: Stanic, Branka Milicic, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0jflkm9eq4hjb45s0t7bb6dhk8